Harter, P., Mouret-Reynier, M., Pignata, S., Cropet, C., González-Martin, A., Bogner, G., Fujiwara, K., Vergote, I., Colombo, N., Mäenpää, J., Floquet, A., El-Balat, A., Lorusso, D., Guerra Alia, E., Fabbro, M., Schmalfeldt, B., Hardy Blessard, A., Runnebaum, I., Pujade-Lauraine, E., & Ray-Coquard, I. (n.d.). phase III PAOLA-1/ENGOT-ov25 trial: olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer treated with platinum-based chemotherapy plus bevacizumab. International journal of gynecological cancer, 29, A10–A11. http://access.bl.uk/ark:/81055/vdc_100144729648.0x00001e